FMR LLC reports 3.48M ACLS shares (11.3%)
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
FMR LLC (and Abigail P. Johnson) report beneficial ownership of 3,479,255.71 shares of Axcelis Technologies Inc. common stock, representing 11.3% of the class as shown on the Schedule 13G/A. The filing lists CUSIP 054540208 and references a power of attorney effective April 13, 2026.
The Schedule notes sole dispositive power of 3,479,255.71 shares and zero shared voting power. Exhibit references include a 13d-1(k)(1) agreement and an Exhibit 99 attachment. Signatures are by a duly authorized representative dated May 6, 2026.
Insights
FMR LLC reports a material passive stake in Axcelis of 11.3%.
FMR LLC and Abigail P. Johnson are shown as beneficial owners of 3,479,255.71 shares, equal to 11.3% of the class according to the Schedule 13G/A dated 04/30/2026. The filing records sole dispositive power and no shared voting power.
Ownership is presented as passive disclosure under Rule 13G/A processes; cash‑flow treatment and any sale intentions are not disclosed in the excerpt. Subsequent filings or exhibits may clarify the subsidiary identity referenced in Exhibit 99.
Key Figures
Key Terms
Schedule 13G/A regulatory
beneficially owned financial
13d-1(k)(1) agreement regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does FMR LLC report in ACLS?
Who else is reported as an owner alongside FMR LLC in the filing?
What exhibits are referenced in the Schedule 13G/A for ACLS?
AI-generated analysis. How Rhea-AI works. Not financial advice.